Ermium receives 1,2 M€ from Bpifrance, the French Innovation agency

Ermium has been granted 1 200 000 € within the frame of the “Aide au Développement Deeptech” program (Support to Deeptech Development) from Bpifrance, the French agency for innovation, to move forward its therapeutic approach for auto-immune diseases including systemic lupus erythematosus, Sjögren’s syndrome and other type I interferon driven diseases